Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«FRAP1

Below is an extended FRAP1 publications listing. Click here to return to the gene page.

Gene Information from Publications

Publication Link Summary of findings
17914450 These data implicate activation of mTOR in the pathogenesis of melanoma, and suggest that Rheb and mTOR may be targets for melanoma therapy.
18048359 a key regulatory role of the Akt/mTOR pathway in the generation of the effects of As(2)O(3)
17372934 Changes in tissue pressure during inflammation may regulate macrophage phagocytosis by activation of PI-3K, which activates Akt2, mTOR, and p70S6K.
18056791 mTOR signaling pathway is playing a role in the greater synthesis of muscle proteins when resistance exercise is followed by essential amino acids and carbohydrate ingestion
17640392 This study identifies the PtdIns(3,4,5)P3-mTOR signaling pathway as a new regulator of iron-transferrin uptake
17996122 analysis of coupled down-regulation of mTOR and telomerase activity during fluorouracil-induced apoptosis of hepatocarcinoma ce
17928295 Bnip3, a hypoxia-inducible Bcl-2 homology 3 domain-containing protein, directly binds Rheb and inhibits the mTOR pathway.
18006825 metformin-mediated AMPK activation leads to inhibition of mTOR and a reduction in translation initiation
16818690 The higher expressions of mTOR protein was associated with worse outcome in glioblastoma.
17935273 Inhibition of mTOR was the idea behind the development of new targeted agents in advanced renal cell carcinoma (Review).
16912159 Mammalian target of rapamycin (mTOR) inhibitor rapamycin enhances the sensitivity of PTEN-deficient tumor cells to the EGFR kinase inhibitor erlotinib
17911267 In breast cancer stem-like cells, the STAT3 pathway was found to be positively regulated by mTOR signaling, whereas PTEN served as a negative regulator of both STAT3 and mTOR signaling.
17991864 findings suggest that FKBP38 is an endogenous inhibitor of mTOR, whose inhibitory activity is antagonized by Rheb in response to growth factor stimulation and nutrient availability
17724079 mTOR inhibition increases eIF4E phosphorylation through a PI3K-dependent and Mnk-mediated mechanism.
17889116 Introduction of mTOR inhibitors to the immunosuppressant regimen in heart transplntation may delay renal functional deterioration caused by calcineurin inhibitors.
17018601 The TSC/Rheb/mTOR pathway plays a critical role in the regulation of E(2)-induced proliferation.
17595159 ULK1 knockdown inhibited rapamycin-induced autophagy consistent with a role downstream of mTOR
17631500 the major mechanism of HER2-mediated induction of FASN and ACCalpha in the breast cancer cells used in this study is translational regulation primarily through the mTOR signaling pathway.
17698027 Finally, using dual-cistronic luciferase constructs we demonstrate that apoB 5' UTR may have weak internal ribosomal entry (IRES) translation which is not affected by insulin stimulation, and may function to stimulate basal levels of apoB translation.
17683115 peptidoglycan make it coincidental the release of arachidonic acid with a rapid induction of cyclooxygenase-2 protein regulated by a signaling cascade involving phosphatidylinositol 3-kinase, mTOR, and the translation machinery
17562705 used 401 to test the cellular effect of mTOR inhibition without the complicating side effects on PI3K
17726467 PLD1 and phospho-mTOR are coexpressed in a subset of phospho-Akt-negative breast carcinomas.
17604271 PRAS40 acts downstream of mTORC1 but upstream of its effectors, such as S6K1 and 4E-BP1
17363738 Withdrawal of Notch signals prevented stimulation of the mTOR pathway by mitogenic factors. These findings collectively suggest that the mTOR pathway is positively regulated by Notch in T-ALL cells
17656678 Proarteriosclerotic effects of interferon gamma are associated with mammalian target of rapamycin raptor complex (mTORC1) and PI-3 kinase activiation.
17565979 P-Rex1 links mTOR signaling to Rac activation and cell migration
17693255 Dysregulation of the tuberous sclerosis 1/mTOR signaling pathway significantly contributes to inflammation-mediated cancer pathogenesis.
17553806 mTOR regulates the phosphorylation and activation of Akt in endothelial cells and a major effect of mTOR inhibition in endothelial cells is to suppress Akt-inducible pro-survival signals
17016437 In multiple myeloma cells mTOR inhibition results a more complete abrogation of VEGF translation, and ultimately, angiogenesis.
17562865 These results strongly suggest that the G1 arrest and the decrease in translation induced by eRF3a depletion are due to the inhibition of mTOR activity and hence that eRF3a belongs to the regulatory pathway of mTOR activity.
17329400 ASCT2 silencing inhibits mTORC1 (mTOR/raptor)signaling and leads to growth repression, followed by enhanced survival signaling via mTORC2 (mTOR/rictor)and apoptosis of hepatoma cells.
12150925 mTOR interacts with Raptor to form a nutrient-sensitive complex that signals to the cell growth machinery.
12150926 mTOR-catalyzed phosphorylation of 4EBP1 in vitro and mTOR action in vivo require the participation of mTOR binding protein, raptor.
12231510 FRAP is a CLIP-170 kinase positively regulating the MT-binding behavior of CLIP-170
15004009 A new form of mTOR elucidates the molecular mechanism underlying mTOR-dependent regulation of RNA synthesis
12820960 Rheb is a mediator of MTOR.
14729629 K-Ras-mediated transformation of intestinal epitelial cells involves activation of the PI3K/mTOR pathway.
16870609 TOR multimerization is a conserved mechanism for TOR functioning
16242075 the inhibition of EGFR and mTOR has distinct as well as common signaling consequences in glioblastoma multiforme cells
16959214 It would seem that this increase in VEGFR-3 occurred via the ERK and mTOR pathways, since their respective inhibitors U0126, LY294002 or rapamycin were responsible for a decrease of VEGFR-3
17028174 Results suggest that FLCN, mutated in Birt-Hogg-Dube syndrome, and its interacting partner FNIP1 may be involved in energy and/or nutrient sensing through the AMPK and mTOR signaling pathways.
17075574 data demonstrate the ubiquitous activation of the mTOR signaling pathway in post-transplant lymphoproliferative disorder
17114181 mTOR-dependent pathways have roles in IFN signaling and 4E-BP1 and TSC1-TSC2 are key components in the generation of IFN-dependent biological responses
17253963 model whereby nutrients signal to mTOR via activation of MAP4K3.
15056668 an intact PI3K/mTOR pathway is necessary for the ability of IFNalpha to induce apoptosis, whereas activation of the Jak-STAT pathway alone appears to be insufficient for this specific IFNalpha-induced effect
14668532 This review describes recent progress in understanding the control of the mTOR signaling pathway and the role of mTOR-interacting proteins.
15723049 S6 kinase 1 is essential for the control of muscle cytoplasmic volume by Akt and mTOR
12807916 mammalian target of rapamycin regulates STAT1-dependent gene transcription by lipopolysaccharide and interferon-gamma
15632115 DGKzeta-derived phosphatidic acid acts as a mediator of mTOR signaling
16786123 mTOR may have a role in increasing survival of cervical cancer patients who are treated with cisplatin-based neoadjuvant chemotherapy
16874098 Results suggest that lysosomal turnover of GABARAP-PL is activated during the differentiation of C2C12 cells to myotubes without inactivation of the mTor kinase-signaling pathway.
16927414 activity assays in Hela cells suggested that,in phase G2 and M, the activity of mTOR was maintained at a higher level than in any other phase
15028555 PI3K mediates G(1) progression and cyclin expression through activation of an AKT/mTOR/p70S6K1 signaling pathway in the ovarian cancer cells.
15489897 PKC-eta targets the Akt and mTOR signaling pathways
15624760 Subependymal giant cell astrocytoma cells show high levels of phospho-S6K, phospho-S6, and phospho-Stat3, all proteins downstream of and indicative of mTOR activation.
16098202 levels of p-mTOR (Ser2481), and p-4E-BP1 (Thr70 and Ser65) dramatically increase in Alzheimer disease, and are positively significantly correlated with total tau and p-tau
16914728 These studies suggest that, through serine phosphorylation, Raptor-mTOR and S6K1 promote the depletion of IRS1 from specific intracellular pools in pathological states of insulin and IGF-I resistance and in lesions associated with tuberous sclerosis.
17289850 IGFBP-2 is regulated predominantly through the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway
12271141 hamartin and tuberin function together to inhibit mammalian target of rapamycin (mTOR)-mediated signaling to eukaryotic initiation factor 4E-binding protein 1 (4E-BP1) and ribosomal protein S6 kinase 1 (S6K1)
15899889 p70S6 kinase is a major effector of mTOR phosphorylation at Ser-2448 in response to both mitogen- and nutrient-derived stimuli
17102641 mTOR is regulatd by polycystin-1 in polycystic kidney disease [review]
14578359 Identification of domains of FRAP/mTOR which may mediate its association with the endoplasmic reticulum and the Golgi apparatus.
15218033 mTOR regulates PP5, which activates apoptosis signal-regulating kinase 1 signaling
15150271 mTOR does not have a role in B-Raf kinase activity regulation by tuberin and Rheb
15292274 Molecular cross-talk between MEK1/2 and mTOR signaling during recovery of 293 cells from hypertonic stress.
15708965 Rrapamycin inhibits fibronectin-induced vascular smooth musscle migration through a pathway that involves mTOR.
12145207 Syncytia from cells expressing the HIV-1 Env gene fused with cells expressing CD4/CXCR4 undergo apoptosis after nuclear translocation of mTOR, mTOR-mediated p53 phosphorylation, p53-dependent Bax upregulation & mitochondrial death pathway activation.
15522880 mTOR may play a major role in IL-12-induced IFN-gamma production by activated T cells
12080086 Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
15623621 Overexpression of phospho-mTOR is associated with liver neoplasms
15659381 RSPRR motif interacts with a negative regulator of S6K1 that is normally suppressed by mTOR.
17215282 inhibition of mTOR by 5'-AMP-activated protein kinase is circumvented
17409838 one rational approach for mTOR-targeted lung cancer therapy is to use an mTOR inhibitor in combination with a drug that blocks PI3K/Akt activation such as a PI3K inhibitor, as we demonstrated in our study.21
17616684 IKK alpha controls mTOR kinase activity in Akt-active, PTEN-null prostate cancer cells, with less involvement by IKK beta
12370290 mTOR substrate specificity is regulated by serine in the rapamycin binding domain
15317677 ANG II activates rapamycin-sensitive mTOR signaling pathway in human coronary smooth muscle cells and involves activation of phosphatidylinositol 3-kinase, p70(S6k), and eukaryotic initiation factor-4E, leading to activation of protein synthesis.
15632201 RTP801 and RTP801L work downstream of AKT and upstream of TSC2 to inhibit mTOR functions
12172553 These functions of TSC1-TSC2 are mediated by inhibition of the mammalian target of rapamycin (mTOR).
15584862 Review. TOR is a transducer of information from various sources, including growth factors, energy sensors, hypoxia sensors, & components regulating growth & division. Blocking TOR mimics amino acid & growth factor deprivation & has a cytostatic effect.
16282343 the mTOR pathway plays an important role during megakaryopoiesis by regulating ploidy, cell size, and maturation, in part by regulating p21 and cyclin D3.
16354680 Raptor directly binds to and serves as a scaffold for mTOR-mediated phosphorylation of IRS-1 on Ser636/639.
16427044 Taken together, these results demonstrate that an intact mTOR pathway is critical for IFN-gamma-induced suppression of pY-STAT3 and apoptosis.
16467080 The mTOR protein activation, as measured indirectly by augmented levels of phospho-S6 protein, was more frequent in tumors with gene alterations in either EGFR or KRAS than in their wild-type counterparts.
16543150 MSL complex interacts with components of the nuclear pore, in particular Mtor/TPR and Nup153. Knockdown of Mtor or Nup153 results in loss of the typical MSL X-chromosomal staining and dosage compensation in Drosophila male cells but not in female cells.
16912980 mTOR kinase hyperactivation is a molecular mechanism underlying the development of cytomegalic neurons
17110454 Bcl-3 is required for condensation of fibrin by activated platelets, demonstrating functional significance for mTOR-regulated synthesis of the protein
17470430 Rheb signaling to mTOR in vivo requires a Rheb switch 2-dependent interaction with an element other than the three known polypeptide components of TOR complex 1
12242281 Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin; These studies position mTOR as an upstream activator of HIF-1 function in cancer cells
15605414 diverse control signals converge on the mTOR-S6K1 signaling pathway
15604215 mTOR/S6K1 overactivation contributes to elevated serine phosphorylation of IRS-1, leading to impaired insulin signaling to Akt in liver and muscle
16099944 T-cad overexpression in vascular endothelial cells protects against stress-induced apoptosis through activation of the PI3K/Akt/mTOR survival signal pathway and concomitant suppression of the p38 MAPK proapoptotic pathway
16141350 simultaneous blockade of mTOR and NF-kappaB pathways synergize to significantly inhibit or abrogate the proliferative responses of BM endothelial cells to mitogenic stimuli
16109716 phospholipase D suppresses protein phosphatase 2A and is involved in the mTOR survival pathway in the transformation of human cells
16286006 mTOR maneuvers on and off the eukaryotic initiation factor 3 translation initiation complex.
11729323 phosphatic acid mediated mitogen activation of mTOR signaling
15905173 S6 kinase 1 is a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase
16006564 Data show that the farnesyl transferase inhibitor (FTI) SCH66336 (lonafarnib) inhibits Rheb farnesylation and mTOR signaling.
16847060 the mTOR pathway regulates mitochondrial oxygen consumption and oxidative capacity
16962653 Results reveal that the SIN1-rictor-mTOR function in Akt-Ser473 phosphorylation is required for TORC2 function in cell survival but is dispensable for TORC1 function.
17148679 These findings suggest that the mTOR signaling pathway is activated and may contribute to cell cycle progression and tumor cell survival in MCL.
17329620 Rapamycin stimulates insulin-mediated glucose uptake in men under conditions known to activate the mTOR pathway.
17482291 the PI3K/AKT/mTOR signaling pathway is involved in regulation of SphK1, with AKT2 playing a key role in PDGF-induced SphK1 expression
17488873 mTOR is inactivated during hypoxia.
17545512 analysis of the mammalian target of rapamycin signaling pathway in cancer [review]
12912989 TOR-signaling and RAIP motifs play distinct roles in the mammalian TOR-dependent phosphorylation of initiation factor 4E-binding protein 1
15388791 The rapid activation of PI3K-Akt/PKB-mTOR-p70(S6K) cascade by T3 provides a new molecular mechanism for thyroid hormone action
15576463 the mTOR pathway is an important modulator of the signals involved in the acute regulation of insulin-stimulated glucose transport in 3T3-L1 and human adipocytes
15452223 Human cytomegalovirus induces mechanisms to maintain the integrity of the eIF4F complex even when mTOR signaling is inhibited.
15001544 Activation of hexosamine pathway affects glucose-induced phosphorylation of IRS-1. Impairs coupling of IRS-1 and PI 3-kinase and activativates Akt/mammalian target of rapamycin/phosphorylated heat- and acid-stable protein-1/p70S6 kinase pathway.
16341243 HIF1a has a role in determining sensitivity to inhibitors of mTOR in kidney cancer
16652388 eukaryotic translation initiation factor 4E binding protein 1(4E-BP1) overexpression is associated with prostate cancer, especially when combined with phosphatase and tensin homolog(PTEN) and mammalian target of rapamycin(mTOR) expression data
16884363 Activation of mammalian target of rapamycin is associated with postmenopausal ovarian endometriosis
16916907 We demonstrate, for the first time in human skeletal muscle, that the regulation of Akt and its downstream signalling pathways GSK-3beta, mTOR and Foxo1 are associated with both the skeletal muscle hypertrophy and atrophy processes.
16954686 levels of mTOR in lymphocytes could follow the cognitive decline in Alzheimer's disease
15878852 binding of mTOR to Rheb mutants that are unable to bind guanyl nucleotide in vivo is inhibited by amino withdrawal; inhibitory effect of amino acid withdrawal is exerted through action on mTOR, at a site distinct from that responsible for binding Rheb
11884412 Atrophy and hypertrophy of skeletal muscle are associated with decreases and increases in Ser(2448) phosphorylation, a site in the mammalian target of rapamycin (mTOR) phosphorylated by protein kinase B (PKB) in vitro.
12558800 the AMPK and mTOR signalling pathways are possibly linked.
16407298 mTOR nuclear import is required for its cytoplasmic signaling to S6K1
14970221 Thr2446 as a novel nutrient-regulated phosphorylation site on mTOR
15580312 identification of an alternative survival signal that is dependent on phospholipase D and mTOR and is active in a breast cancer cell line where the phosphatidylinositol-3-kinase survival pathway is not active
12604610 raptor binds to p70S6k and 4E-BP1 through their respective TOS (conserved TOR signaling) motifs.
15496972 stromal cell-mediated apoptotic protection in B-lineage ALL is mediated by PI3K/mTOR and MEK via a synergistic mechanism
15802268 EGF and hypoxia induce CXCR4 in non-small cell lung cancer, a process regulated by the PI3-kinase/PTEN/AKT/mTOR signaling pathway and activation of HIF-1alpha
15657358 An inhibitor of this and of the EGF receptor pathwway inhibits growth of glioma in a xenograft mousse model.
15702344 During recovery, the inhibition of mTOR by AMPK is suppressed, and its activation is maximized by the presence of AA.
16027121 activation of mTOR by Akt-mediated cellular energy and inhibition of AMPK is the predominant pathway by which Akt activates mTOR in vivo
16183647 A redox-sensitive mechanism regulates the phosphorylation of the raptor-mTOR effector S6K1, the interaction between raptor and mTOR, and the kinase activity of the raptor-mTOR complex.
16929481 eIF3i overexpression fosters the integration of growth signals by mTOR into the mRNA translation process, promoting protein synthesis and tumor growth.
16963469 Phosphorylated-mTOR levels and mTOR activity were dramatically increased in HEK 293 cells with RIalpha levels reduced by siRNA.
17052453 S6K1 regulates GSK3 under conditions of mTOR-dependent feedback inhibition of Akt
17318075 mTOR pathway is active in 40% of patients with hepatocellular carcinomas undergoing orthotopic liver transplantation
17461779 It was demonstrated that immunoprecipitation of Protor-1 or Protor-2 results in the co-immunoprecipitation of other mTORC2 subunits, but not Raptor, a specific component of mTORC1.
17616691 AKT amplification and the mTOR/p70S6K1 pathway play an important role in human lung cancer cells acquiring CDDP resistance
12000755 Predominant nuclear localization in normal and malignant cells in culture.
12813467 mTOR is a critical target for survival signals generated by phospholipase D in breast cancer cells.
15718470 results show show that target of rapamycin (TOR) kinase and its associated protein rictor are necessary for AKT/PKB Ser473 phosphorylation and that a reduction in rictor or mammalian TOR (mTOR) expression inhibited an Akt/PKB effector
16049009 hVps34 is a nutrient-regulated lipid kinase that integrates amino acid and glucose inputs to mTOR and S6K1
15953364 The mainly anti-apoptotic mTOR signalling is downregulated in cellular and transgenic models of Alzheimer's disease and in peripheral cells of patients, and could contribute to the pathogenesis of the disease.
16824195 4E-BP1 binds to eukaryotic initiation factor-4E (eIF4E) to prevent the formation of the active translation complex and dissociates from eIF4E by phosphorylation through the mammalian target of rapamycin (mTOR) in the cells stimulated by amino acids.
16849522 Inhibition of mammalian target of rapamycin (mTOR) with rapamycin (10-100 nmol/L) had no significant effect on HIF-1alpha induction in a variety of cell lines, a finding that was confirmed using mTOR siRNA.
17351147 A bout of aerobic exercise restores the anabolic response of muscle proteins to insulin by improving endothelial function and Akt/mTOR signaling in older subjects.
17463046 mTOR functions as a placental nutrient sensor, matching fetal growth with maternal nutrient availability by regulating placental nutrient transport. Provide a mechanism for the changes in placental leucine transport in intrauterine growth retardation.
17483438 vascular endothelial growth factor by Akt and mammalian target of rapamycin inhibitors in cell lines derived from childhood solid tumors
11691993 The mTOR pathway is influenced by the intracellular concentration of ATP, independent of the abundance of amino acids, and mTOR itself is an ATP sensor.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.